Orthopaedic manifestations of the antiphospholipid (Hughes) syndrome

Lupus

Volumn 14, Issue 5, 2005, Pages 339-345

  Vasoo, S ^a,b   Sangle, S ^a   Zain, M ^a   D'Cruz, D ^a   Hughes, G ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Antiphospholipid syndrome; Avascular necrosis; Fractures; Orthopaedics

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; AVASCULAR NECROSIS; BONE DISEASE; BONE MARROW NECROSIS; BONE NECROSIS; BRAIN DISEASE; CARDIOLOGY; CLINICAL FEATURE; CLINICAL PROTOCOL; COMPLEX REGIONAL PAIN SYNDROME TYPE I; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; EDEMA; ERYTHEMA; EYE DISEASE; FRACTURE; GASTROENTEROLOGY; HEART DISEASE; HUMAN; KIDNEY DISEASE; LIMB DISEASE; LIVER DISEASE; MORBIDITY; NEPHROLOGY; NEUROLOGY; OBSTETRICS; ORTHOPEDICS; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYMPTOM; VEIN THROMBOSIS;

ANTIPHOSPHOLIPID SYNDROME; BONE DISEASES; BONE MARROW DISEASES; FRACTURES, BONE; HUMANS; OSTEONECROSIS; REFLEX SYMPATHETIC DYSTROPHY;

EID: 19944371157     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2146rr     Document Type: Review

References (49)

1. Sangle S, D'Cruz D, Khamashta MA, Hughes GRV. Antiphospholipid antibodies, systemic lupus erythematosus and non-traumatic metatarsal fractures. Ann Rheum Dis 2004; 63: 1241-1243.
2. Hughes GRV. Thrombosis, abortion, cerebral disease and the lupus anticoagulant. BMJ 1983; 287: 1088-1089.
3. Froberg PK, Braunstein EM, Buckwater KA. Osteonecrosis, transient osteoporosis. Radiol Clin N Am 1996; 34: 273-291.
4. Phemister DB. Fracture neck of femur, dislocation of hip and obscure vascular disturbances producing aseptic necrosis of the head of the femur. Surg Gynaec Obstet 1934; 59: 415-440.
5. Asherson R, Liote F, Page B et al. Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol 1993; 20: 284-288.
6. Hughes GRV. Off the beaten track: a clinician's view. In Khamashta MA ed. Hughes' syndrome (antiphospholipid syndrome). London: Springer. 2000: 105-110.
7. Nagasawa K, Ishii Y, Mayumo T et al. Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities. Ann Rheum Dis 1989; 48: 672.
8. Alarcon-Segovia D, Deleze M, Oria CV et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1990; 68: 353-365.
9. Migliaresi S, Picillo U, Ambrosone L et al. Avascular necrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies. Lupus 1994; 3: 37-41.
10. Mont MA, Glueck CJ, Pachet IH, Hungerford DA, Wang P, Petri M. Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol 1997; 24: 654-662.
11. Houssiau FA, N'Zeusseu Toukap A, Depresseux G et al. Magnetic resonance imaging-detected avascular necrosis in systemic lupus erythematosus: lack of correlation with antiphospholipid antibodies. Br J Rheumatol 1998; 37: 448-453.
12. Mok CC, Lau CS, Wong RWS. Risk factors for avascular necrosis in systemic lupus erythematosus. Br J Rheumatol 1998; 37: 895-900.
13. Mok MY, Farewell VT, Isenberg DA. Risk factors for avascular necrosis of bone in systemic lupus erythematosus: is there a role for antiphospholipid antibodies? Ann Rheum Dis 2000; 59: 462-467.
14. Gladman DD, Urowitz MB, Chaudhry-Ahluwalia V, Hallet DC, Cook RJ. Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus. J Rheumatol 2001; 28: 761-765.
15. Glueck CJ, Freiberg R, Tracey T, Stoop D, Wang P. Thrombophilia and hypofibrinolysis. Pathophysiologies of osteonecrosis. Clin Orthop 1997; 334: 43-56.
16. Jones JP Jr. Risk factors potentially activating intravascular coagulation and causing nontraumatic osteonecrosis. Chapter 12. In Urbaniak JR, Jones JP Jr, eds. Osteonecrosis. Rosemont, IL: AAOS. 1997.
17. Laroche M, Ludot I, Thiechart M, Viguier G, Dromer C, Mazieres B. Histological appearance of the intra-osseous vessels of the femoral head in aseptic necrosis of the hip, with or without antiphospholipid antibodies. Clin Rheumatol 1997; 16: 367-371.
18. Tektonoidou MG, Malagari K, Vlachoyiannopoulos PG, Kelekis DA, Moutsopoulos HM. Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: a prospective study by magnetic resonance imaging. Arthritis Rheum 2003; 48: 732-736.
19. Alijotas J, Argemo M, Barquinero J. Kienbock's disease and antiphospholipid antibodies. Clin Exp Rheumatol 1990; 8: 297-298.
20. Vela P, Batlle E, Salas E, Marco P. Primary antiphospholipid syndrome and osteonecrosis [letter]. Clin Exp Rheumatol 1991; 9: 545-546.
21. Seleznick MJ, Silveira LH, Espinoza LR. Avascular necrosis associated with anticardiolipin antibodies. J Rheumatol 1991; 18: 1416-1417.
22. Egan RM, Munn RK. Catastrophic antiphospholipid syndrome presenting with multiple thromboses and sites of avascular necrosis. J Rheumatol 1994; 21: 2376-2379.
23. Jones LC, Mont MA, Le BT et al. Procoagulants and osteonecrosis. J Rheumatol 2003; 30: 783-791.
24. Miller KD, Masur H, Jones EC et al. High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med 2002; 137: 17-25.
25. Mok MY, Isenberg DA. Avascular necrosis of a single vertebral body, an atypical site of disease in secondary APLS. Ann Rheum Dis 2000; 59: 494-495.
26. Yoo WH. Multiple rib infarcts: a rare form of osteonecrosis in antiphospholipid syndrome. Ann Rheum Dis 2004; 63: 457-458.
27. Tsutsumi A, Horita T, Ohmuro J et al. Reflex sympathetic dystrophy in a patient with the antiphospholipid syndrome. Lupus 1999; 8: 471-473.
28. Eulry F, Bauduceau B, Clement R et al. Algodystrophy and venous thrombosis of the lower extremities. Diagnostic discussion. Apopros of 3 cases. Phlebologie 1987; 40: 251.
29. Eulry F, Chazerain P, Magnin J et al. Algodystrophy and venous thrombosis of the lower limbs: diagnostic problems. Apopros of 5 cases. Rev Rhum Mal Osteoartic 1989; 56: 403.
30. Sundaram S, Webster GF. Vascular diseases are the most common cutaneous manifestation of reflex sympathetic dystrophy. J Am Acad Dermatol 2001; 44: 1050-1051.
31. Webster GF, Schwartzman RJ, Jacoby RA, Knobler RL, Uitto JJ. Reflex sympathetic dystrophy. Occurrence of inflammatory skin lesions in patients with stages II and III disease. Arch Dermatol 1991; 127: 1541-1544.
32. Bulvik S, Aronson I, Ress S, Jacobs P. Extensive bone marrow necrosis associated with antiphospholipid antibodies. Am Med J 1995; 98: 572-574.
33. Paydas S, Kocak R, Zorludemir S, Baslamisli F. Bone marrow necrosis in antiphospholipid syndrome. J Clin Pathol 1997; 50: 261-262.
34. Murphy PT, Sivakumaran M, Casey MC, Liddicoat J, Wood JK. Lymphoma associated bone marrow necrosis with raised anticardiolipin antibody. J Clin Pathol 1998; 51: 407-409.
35. Moore J, Ma DD, Concannon A. Non-mailgnant bone marrow necrosis: a report of two cases. Pathology 1998; 30: 319-320.
36. Schaar CG, Ronday KKH, Boets EP, van der Lubbe PA, Breedveld FC. Catastrophic manifestation of the antiphospholipid syndrome. J Rheumatol 1999; 26: 2261-2264.
37. Sinha J, Chowdhry I, Sedan S, Barland P. Bone marrow necrosis and refractory HELLP syndrome in a patient with catastrophic antiphospholipid syndrome. J Rheumatol 2002; 29: 195-197.
38. Thuerl C, Altehoefer C, Spyridonidis A, Laubenberger J. Imaging findings in the rare catastrophic variant of primary antiphospholipid syndrome. Eur Radiol 2002; 12: 545-548.
39. Spyropoulos AC. Membranous obstruction of the inferior vena cava and extensive bone marrow necrosis associated with catastrophic antiphospholipid syndrome. J Clin Rheumatol 1999; 5: 279-284.
40. Levine J, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-763.
41. Glueck CJ, Freiberg RA, Wang P. The role of thrombosis in osteonecrosis. Curr Hematol Rep 2003; 2: 417-422.
42. Bicks RL, Arun B, Frenkel EP. Antiphospholipid-thrombosis syndromes. Haemostasis 1999; 29: 100-110.
43. Caprini JA, Glase CJ, Anderson CB, Hathaway K. Laboratory markers in the diagnosis of venous thromboembolism. Circulation 2004; 109(Suppl.): I4-I8.
44. Geerts WH, Heit JA, Clagett GP et al. Prevention of venous thromboembolism. Chest 2001; 119(Suppl.) 132S-175S.
45. Vikoren TH, Fenwick JA, Cross BJ, Ragni MV, Gruen GS. Antieardiolipin antibody-associated arterial thrombosis following fibula fracture. Foot Ankle Int 2003; 24: 270-273.
46. Asherson RA, Chan JK, Harris EN, Gharavi AE, Hughes GR. Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal. Ann Rheum Dis 1985; 44: 823-825.
47. Yammamoto T, Ito M, Nagata S et al. Catastrophic exacerbation of antiphospholipid syndrome after lung adenocarcinoma biopsy. J Rheumatol 2000; 27: 2035-2037.
48. Asherson RA, Cervera R, Lie JT. The antiphospholipid syndromes. In Lahita RG ed. Systemic lupus erythematosus. San Diego: Academic Press, 1999: 829-870.
49. Erkan D, Leibowitz E, Berman J, Lockshin MD. Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations. J Rheumatol 2002; 20: 843-849.